Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Control Bionics Ltd. ( (AU:CBL) ) has issued an announcement.
Control Bionics Limited has announced the quotation of 32,874,567 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 17, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial standing and visibility in the market, potentially benefiting stakeholders by increasing the liquidity and marketability of its shares.
More about Control Bionics Ltd.
Control Bionics Limited operates in the technology industry, focusing on developing and providing advanced communication and control solutions for individuals with disabilities. The company is known for its innovative products that enhance the quality of life for people with severe physical impairments, enabling them to communicate and interact with the world more effectively.
Average Trading Volume: 137,709
Technical Sentiment Signal: Sell
Current Market Cap: A$12.02M
For detailed information about CBL stock, go to TipRanks’ Stock Analysis page.